GIFFIN BRETT A. (Chief Commercial Officer) purchased 10.60K shares of T2 BIOSYSTEMS, INC. on the open market
Open‑market purchase worth $5.2K. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 4/11/2022ACC: 0000899243-22-014412
Officer· Chief Commercial Officer
Since Nov 2021
+10.60K
Net shares
Net buyer
$5.2K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
10.60K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+10.60K
Price / share
$0.49
Trade value
$5.18K
% of position
New position
4/8/2022
0.00→10.60K
Total
Net shares
+10.60K
Net value
$5.18K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/8/2022 | P · Purchase | +10.60K | $0.49 | $5.18K | New position | 0.00 | 10.60K |
| Total | +10.60K | $5.18K | ||||||
Derivative Transactions0
No derivative transactions reported